Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation.
In this commentary, we summarize the most recent advances in the cytokine-targeting therapies. We focus on new aspects of interleukin-1 (IL-1)-mediated autoinflammation and novel strategies to target IL-1.
Arthritis and Tissue Degeneration Program and Department of Medicine, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA.
George D
GD
Kalliolias
Lionel B
LB
Ivashkiv